Zac Mirecki reflects on six years of survivorship, sharing how his AML journey taught him to priori-tize self-care, seek ...

Cancer is nonpartisan. It touches everyone — cutting across religion, race, ethnicity, sexual orientation and socioeconomic ...

Fear is a powerful enemy of the mind but there’s another word that has the same power. That word is a six letter one, cancer.

Learning I carried the BRCA1 mutation was terrifying, but it gave me the power to choose prevention, embrace survivorship, ...

A significant development in the treatment of advanced melanoma has recently emerged: tumor-infiltrating lymphocyte (TIL) ...

Nine years after my bladder cancer diagnosis, I reflect on its recurrence, caregiving, grief, and my new life with leukemia ...

Mark Daniels, 83, says CAR T-cell therapy and strong support helped him overcome lymphoma twice and return to the ...

Tamron Little was diagnosed with peritoneal mesothelioma in 2007 as a 21-year-old new mother. Catch up on Tamron's blogs here ...

The FDA approved Lynozyfic for relapsed multiple myeloma, but serious risks require restricted use under a special safety ...

Breaking down what patients should know about each FDA therapeutic approval from June 2025 across various oncology ...

T cells are a natural part of the immune system designed to fight infections and cancer, but in conditions like blood cancer, ...

Patients in rural or underserved areas may have worse outcomes, highlighting the need for early support to address care ...